CLOSE

Specials

I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

Skip to: Curated Story Group 1
Life Sciences Review
US
EUROPE
CANADA

About Us

Conference

Partner With Us

  • APAC
    • US
    • EUROPE
    • CANADA
    • LATAM
  • Drug Discovery
    Antibodies
    Bioinformatics & Genomics
    BioTech
    Cell and Gene Therapy
    Drug Discovery and Development
    Life Science AI
    Next-Generation Sequencing
    Therapeutics
  • Biomanufacturing
    Biomanufacturing
    CDMO
    Cosmetic
    CRO
    Life Science Testing And Compliance
    Supplement Manufacturing
  • Business Services
    Life Science Consulting
    Life Sciences Marketing and Communication
  • Leadership Perspectives
  • Innovation Insights
  • News
  • Magazines
×
#

Life Science Review Weekly Brief

Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Life Science Review

Subscribe

loading

This article is part of Life Sciences Review's Innovation Insights series featuring expert contributions nominated by our subscribers and reviewed by our editorial team.

Max Wang,  Shanghai MediumBank Biotechnology | Life Science Review | Top Cell and Gene Therapy Company in Japan

Shanghai MediumBank: Powering Bioprocess Innovation with Customized Media Solutions

Max Wang, CEO and the Head of the R&D Department , Shanghai MediumBank Biotechnology

Bioprocess Innovation Architect

Editor’s Note: Biopharmaceutical manufacturers are under growing pressure to accelerate biologics production without compromising scalability, quality or cost control. This perspective highlights why customized media development and intelligent bioprocess optimization are becoming critical competitive differentiators across the life sciences industry.

At Shanghai MediumBank, we recognize that a successful biotherapeutic hinges on the critical balance of speed, cost, and supply chain reliability. We move beyond being a mere media supplier to offer a core, integrated service: our Media Optimization & Development (MOD) Service. This service leverages our five synergistic technical platforms to deliver custom solutions that directly accelerate your time-to-market, optimize costs, and ensure a stable, scalable supply.

Our Core Offering: The Media Optimization & Development (MOD) Service

When off-the-shelf media are not enough, our MOD service is your definitive pathway to a bespoke, high-performance solution. We partner with you to design and deliver optimized media formulations that target your specific cell line and process goals—maximizing final titer and critical quality attributes (CQAs).

• Accelerated Timelines for Faster Commercialization: Our data-driven approach, powered by proprietary AI models and extensive platform data, compresses development cycles. We have consistently helped clients achieve 3 to 8-fold increases in titer within months, dramatically shortening the critical path from clone to clinic.
• Cost Optimization Through Precision Formulation: By identifying the exact nutritional requirements and limitations of your process, we eliminate unnecessary components and inefficiencies. This precision engineering translates into a more cost-effective media that enhances productivity without compromising quality.
• Built for Stable, Scalable Supply from the Start: Every MOD project is developed with manufacturability in mind. Our formulations are seamlessly transferred to our Medium Process Development (MPD) Platform, ensuring robust, scalable production with rigorous batch-to-batch consistency, securing your supply chain from clinical trials to commercial launch.

The Five Integrated Platforms Powering MOD Excellence

Our MOD service draws its unique strength from a foundation of five interlinked, proprietary technical platforms:

1. Raw Material Characterization Platform: Ensures unparalleled starting quality and consistency through advanced analytical control of every raw material, building a reliable supply chain foundation.

2. Artificial Intelligence Medium Development (AIMD) Platform: The brain of our operation. It utilizes AI, machine learning, and multi-omics data (like transcriptomics) to rapidly decode cell metabolism and generate superior, cell-line-specific formulations with unmatched efficiency.
3. Cell Culture Technology (CCT) Platform: Provides the essential biological validation across diverse systems—from fed-batch and perfusion to viral vector production—ensuring your custom media performs flawlessly in your actual process.
4. Analytical & Testing Technology Platform: Guarantees safety and efficacy through deep analytical insight. Our high-throughput mass spectrometry capabilities deliver full-component analysis of media and spent culture fluid for precise optimization.
5. Medium Process Development (MPD) Platform: The critical bridge from formula to reliable product. It transforms optimized formulations into stable, manufacturable powder or liquid media at scale (up to 600kg powder / 2000L liquid batches), ensuring consistent performance in your facility.
  • We believe the success of a biotherapeutic product begins with a precise, scalable, and stable media strategy. Our integrated platforms and MOD service deliver customized, scalable solutions that accelerate time-to-market, optimize costs, and ensure supply chain reliability, turning scientific potential into commercial reality.


Comprehensive Support for Your Bioprocess Journey

Beyond MOD, we offer specialized services to support your entire workflow:
• Standardized Cell Culture Media: High-performance, ready-to-use media for CHO, HEK293, and MSC platforms.
• Customized Manufacturing: Rapid scale-up of your proprietary formula via our Rapid Powder Production (RPP) or Efficient Hydrate Solution (EHS) services.
• Spent Media Analysis (SMA): A data-driven service to diagnose process bottlenecks and enable continuous improvement.

Your Partner in Bioprocess Innovation

The experts at Shanghai MediumBank are committed to being your strategic partner. We combine advanced science with commercial pragmatism to deliver solutions that are not only technically superior but also commercially astute—designed to reduce risk, control cost, and accelerate your critical timelines.

Contact us today at mediumbank@mediumbank.net to discover how our MOD service and integrated platforms can power your next breakthrough.

MORE FROM INNOVATION INSIGHTS

Bringing Genetic Science Into Daily Health Decisions
CRI Genetics
Alex Mulyar, Founder

Bringing Genetic Science Into Daily Health Decisions

Why to outsource disinfectant efficacy testing (DET) to a centralized laboratory
Labor LS
Anastasija Schlicht, Head of Disinfectant Efficacy Testing (DET)

Why to outsource disinfectant efficacy testing (DET) to a centralized laboratory

Navigating the Global Omega-3 Market: How to Identify a Reliable Liquid Supplement Manufacturer
Valentis
Linas Kamarauskas, Business Development Manager

Navigating the Global Omega-3 Market: How to Identify a Reliable Liquid Supplement Manufacturer

Solving Canada's Pharma Talent Gap with AI and Automation
CSols Inc
Becky Stewart, Scientific Copywriter

Solving Canada's Pharma Talent Gap with AI and Automation


EXPLORE OUR KNOWLEDGE NETWORK


View Innovation InsightsRead Leadership Perspectives

The articles from these contributors are based on their personal expertise and viewpoints, and do not necessarily reflect the opinions of their employers or affiliated organizations.

Thank you for Subscribing to Life Science Review Weekly Brief

Life Sciences Review APAC
Follow on LinkedIn

About

  • Home
  • About Us
  • Partner With Us

Stay Connected

  • Subscribe
  • Newsletter
  • Sitemap

Contact Us

  • editor@lifesciencesreview.com
  • sales@lifesciencesreview.com
  • marketing@lifesciencesreview.com

Legal

  • Editorial Policy
  • Privacy Policy
  • Terms of Use

© 2026 Life Sciences Review APAC. All rights reserved. Headquartered in Fort Lauderdale, FL, USA.

This content is copyright protected

However, if you would like to share the information in this article, you may use the link below:

https://www.lifesciencesreviewapac.com/innovation-insight/shanghai-mediumbank-powering-bioprocess-innovation-with-customized-media-solutions-cid-2328